Skip to main content

Want a detailed portfolio tracker?

Y-Mabs Therapeutics (YMAB) Operating Margin (2021 - 2025)

Y-Mabs Therapeutics (YMAB) operating margin from Mar 31, 2021 to Jun 30, 2025. The current Y-Mabs Therapeutics (YMAB) operating margin is -28.69%. You can export chart.

Annual Operating Margin

Quarterly Operating Margin

Annual Operating Margin change of Y-Mabs Therapeutics (YMAB)

YearOperating MarginChange
2024-35.58%
+17.56%
2023-30.26%
-79.17%
2022-145.26%
-56.08%
2021-330.74%
-42.78%
2020-577.98%
N/A

Comparison Y-Mabs Therapeutics (YMAB) operating margin with competitors

Y-Mabs Therapeutics (YMAB) operating margin is -28.69%.

TickerNameOperating MarginUpside
VIRVir Biotechnology Inc459241.00%-1600882.91%
APLMApollomics Inc - Class A431.90%-1605.48%
ABUSArbutus Biopharma Corp94.30%-428.70%
SAVACassava Sciences Inc.93.36%-425.43%
RPRXRoyalty Pharma plc - Class A89.29%-411.24%
GLPGGalapagos NV84.24%-393.64%
NEUPNeuphoria Therapeutics Inc79.85%-378.33%
BDTXBlack Diamond Therapeutics Inc77.90%-371.54%
CTNMContineum Therapeutics Inc - Class A77.87%-371.43%
CVACCureVac N.V.74.59%-360.00%
IPSCCentury Therapeutics Inc67.95%-336.85%
FULCFulcrum Therapeutics Inc65.62%-328.73%
AVIRAtea Pharmaceuticals Inc63.06%-319.81%
PLXProtalix BioTherapeutics Inc62.65%-318.38%
PRTAProthena Corporation plc58.80%-304.96%
AUPHAurinia Pharmaceuticals Inc53.31%-285.82%
ADMAAdma Biologics Inc50.90%-277.42%
RPTXRepare Therapeutics Inc50.85%-277.25%
CRMDCorMedix Inc49.96%-274.15%
HCWBHCW Biologics Inc49.78%-273.52%
CPRXCatalyst Pharmaceuticals Inc49.02%-270.87%
SRPTSarepta Therapeutics Inc49.00%-270.80%
HALOHalozyme Therapeutics Inc48.98%-270.73%
KRYSKrystal Biotech Inc46.14%-260.83%
AGENAgenus Inc44.62%-255.53%
CGENCompugen Ltd43.05%-250.06%
SVASinovac Biotech Ltd42.30%-247.45%
EXELExelixis Inc41.15%-243.44%
QTTBQ32 Bio Inc39.80%-238.73%
INVAInnoviva Inc38.94%-235.73%
VRTXVertex Pharmaceuticals Inc38.10%-232.81%
NXTCNextcure Inc36.70%-227.93%
LGNDLigand Pharmaceuticals Inc - Class B33.58%-217.05%
SLNOSoleno Therapeutics Inc33.06%-215.24%
JAZZJazz Pharmaceuticals plc31.49%-209.77%
ARGXArgen X SE30.35%-205.79%
CAICaris Life Sciences Inc - Class A30.19%-205.23%
TNGXTango Therapeutics Inc26.15%-191.15%
GMABGenmab25.11%-187.53%
ZVRAZevra Therapeutics Inc24.40%-185.05%
TECHBio-Techne Corp24.24%-184.49%
INCYIncyte Corp23.66%-182.47%
RIGLRigel Pharmaceuticals20.21%-170.45%
ICCCImmucell Corp19.01%-166.26%
REGNRegeneron Pharmaceuticals Inc17.83%-162.15%
NERVMinerva Neurosciences Inc17.73%-161.80%
HRMYHarmony Biosciences Holdings Inc17.31%-160.34%
TGTXTG Therapeutics Inc16.98%-159.19%
BMRNBiomarin Pharmaceutical Inc16.92%-158.98%
ONCBeiGene Ltd16.51%-157.55%
PTCTPTC Therapeutics Inc16.50%-157.51%
ENVBEnveric Biosciences Inc13.38%-146.64%
VXRTVaxart Inc13.19%-145.98%
VRNAVerona Pharma Plc12.90%-144.97%
ALNYAlnylam Pharmaceuticals Inc12.01%-141.86%
ASNDAscendis Pharma A/S10.06%-135.07%
APLSApellis Pharmaceuticals Inc9.86%-134.37%
FOLDAmicus Therapeutics Inc8.61%-130.01%
CGEMCullinan Oncology Inc7.24%-125.24%
IMCRImmunocore Holdings plc6.82%-123.77%
NAGENiagen Bioscience Inc5.01%-117.46%
NUVBNuvation Bio Inc - Class A4.66%-116.24%
BMEABiomea Fusion Inc2.46%-108.57%
TLXTelix Pharmaceuticals Ltd1.58%-105.51%
HOTHHoth Therapeutics Inc0.17%-100.59%
BBLGBone Biologics Corp0.04%-100.14%